Swiss National Bank’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $166M | Buy |
|
|||||
|
2021
Q1 | $129M | Buy |
|
|||||
|
2020
Q4 | $129M | Sell |
|
|||||
|
2020
Q3 | $98.4M | Sell |
|
|||||
|
2020
Q2 | $98.3M | Buy |
|
|||||
|
2020
Q1 | $77.1M | Buy |
|
|||||
|
2019
Q4 | $76.5M | Sell |
|
|||||
|
2019
Q3 | $72.5M | Buy |
|
|||||
|
2019
Q2 | $95.4M | Sell |
|
|||||
|
2019
Q1 | $101M | Buy |
|
|||||
|
2018
Q4 | $70.5M | Buy |
|
|||||
|
2018
Q3 | $98.7M | Sell |
|
|||||
|
2018
Q2 | $91M | Buy |
|
|||||
|
2018
Q1 | $79.9M | Sell |
|
|||||
|
2017
Q4 | $98.4M | Sell |
|
|||||
|
2017
Q3 | $116M | Buy |
|
|||||
|
2017
Q2 | $99.9M | Buy |
|
|||||
|
2017
Q1 | $96.3M | Buy |
|
|||||
|
2016
Q4 | $76.4M | Buy |
|
|||||
|
2016
Q3 | $76.2M | Sell |
|
|||||
|
2016
Q2 | $73.7M | Buy |
|
|||||
|
2016
Q1 | $78.1M | Buy |
|
|||||
|
2015
Q4 | $78.4M | Buy |
|
|||||
|
2015
Q3 | $62.6M | Buy |
|
|||||
|
2015
Q2 | $65.4M | Buy |
|
|||||
|
2015
Q1 | $52.3M | Buy |
|
|||||
|
2014
Q4 | $33.9M | Sell |
|
|||||
|
2014
Q3 | $31.4M | Sell |
|
|||||
|
2014
Q2 | $30.1M | Buy |
|
|||||
|
2014
Q1 | $28.9M | Sell |
|
|||||
|
2013
Q4 | $27.7M | Sell |
|
|||||
|
2013
Q3 | $24.5M | Buy |
|
|||||
|
2013
Q2 | $19.2M | Buy |
|